The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Daniel Cho

Division of Hematology and Oncology

Beth Israel Deaconess Medical Center

Boston

Massachusetts; Comprehensive Cancer Centers of Nevada

Nevada

[email]@*.harvard.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Comprehensive Cancer Centers of Nevada, Nevada. 2009 - 2012
  • Beth Israel Deaconess Medical Center, Boston, MA 02215, and Department of Microbiology and Molecular Genetics, USA. 2007

References

  1. Two phase 2 trials of the novel Akt inhibitor perifosine in patients with advanced renal cell carcinoma after progression on vascular endothelial growth factor-targeted therapy. Cho, D.C., Hutson, T.E., Samlowski, W., Sportelli, P., Somer, B., Richards, P., Sosman, J.A., Puzanov, I., Michaelson, M.D., Flaherty, K.T., Figlin, R.A., Vogelzang, N.J. Cancer (2012) [Pubmed]
  2. The efficacy of the novel dual PI3-kinase/mTOR inhibitor NVP-BEZ235 compared with rapamycin in renal cell carcinoma. Cho, D.C., Cohen, M.B., Panka, D.J., Collins, M., Ghebremichael, M., Atkins, M.B., Signoretti, S., Mier, J.W. Clin. Cancer Res. (2010) [Pubmed]
  3. Retrospective analysis of the safety and efficacy of interleukin-2 after prior VEGF-targeted therapy in patients with advanced renal cell carcinoma. Cho, D.C., Puzanov, I., Regan, M.M., Schwarzberg, T., Seery, V., Lee, M.Y., Liu, V., Bhatt, R., Koon, H., Mier, J.W., Sosman, J.A., Atkins, M.B., McDermott, D.F. J. Immunother. (2009) [Pubmed]
  4. Potential histologic and molecular predictors of response to temsirolimus in patients with advanced renal cell carcinoma. Cho, D., Signoretti, S., Dabora, S., Regan, M., Seeley, A., Mariotti, M., Youmans, A., Polivy, A., Mandato, L., McDermott, D., Stanbridge, E., Atkins, M. Clin. Genitourin. Cancer (2007) [Pubmed]
 
WikiGenes - Universities